Back

Stopping anticoagulation in VTE. Is there a risk?

2 September 2019 (10:15 - 10:25)
Organised by:
Congress Presentation Part of: The chronic risk of venous thrombosis: tailoring extended prevention with NOACs Prevention ESC Premium Access ESC Congress 2019

About the speaker

Photo
Professor Saskia Middeldorp

Amsterdam University Medical Centre (AUMC), Amsterdam (Netherlands (The))

2 More presentations in this session

Presentation thumbnail
How evidence will change practice: VTE guideline recommendation in focus
Professor S. Konstantinides (Mainz, DE)
Slides Video
Presentation thumbnail
The chronic risk of venous thrombosis - Discussion
Professor S. Konstantinides (Mainz, DE) Professor S. Middeldorp (Amsterdam, NL)
Video

Access the full session

Session thumbnail
The chronic risk of venous thrombosis: tailoring extended prevention with NOACs

The Event

Event poster

ESC Congress 2019

2 September 2019 10:15 CET
You may be interested in
thumbnail
Webinar
ESC Guidelines on Acute Pulmonary Embolism ? practical guidance into clinical practice. Part 2: challenges of managing PE in the long term
11 March 2021
thumbnail
Congress Presentation
Permanent discontinuation of different anticoagulants in patients with atrial fibrillation and the impact on clinical outcome: data from the GARFIELD-AF registry
31 August 2020
thumbnail
Congress Presentation
Anticoagulant treatment patterns and thromboembolic events by tumor type among patients with VTE and cancer
28 August 2022
thumbnail
Congress Presentation
Antithrombotic therapy during TAVI and peri-interventional management of antithrombotic therapy.
28 August 2022

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources